We are live on ! Find out more
DRGS

RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS

Delisted

DRGS was delisted on the 6th of July, 2015.

Back to rankings

4 hedge funds and large institutions have $352K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $263K → $352K (+$89.2K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$65.4K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$9.19K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$335K +$65.4K +1,145 +26%
AIG
2
American International Group
New York
$11.9K – – –
UBS Group
3
UBS Group
Switzerland
$5K -$9.19K -161 -64%

DRGS Hedge Fund Activity: Q1 2015 in Review

4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q1 2015, worth a combined $352K — up 34% from $263K a quarter earlier.

Fund positioning in DRGS was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, adding an estimated $65.4K. The largest seller was UBS Group, cutting an estimated $9.19K.

  • 4 institutional investors held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $352K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q1 2015, up 34% quarter-over-quarter.
  • 0 funds opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q1 2015 and 0 closed out.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q1 2015 was Jane Street, an estimated $65.4K added.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q1 2015 was UBS Group, an estimated $9.19K sold.

Based on aggregated 13F filings for Q1 2015.